Menu

Choice of prosthetic heart valves:update for the next generation

By Bach D.S. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

The next generation of prosthetic heart valves needs a proven track record of patient outcomes at >=15 to 20 years

By Rahimtoola S.H. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Validation of Mayo clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry

By Singh M., Rihal C.S., Selzer F., Kip K.E., Detre K., Holmes D.R. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Risk score for percutaneous coronary intervention: forewarned is forearmed

By de Feyter P.J., McFadden E. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Arterial remodeling patterns before intervention predict diffuse in-stent restenosis - An intravascular ultrasound study

By Sahara M., Kirigaya H., Oikawa Y., Yajima J., Ogasawara K., Satoh H., Nagashima K., Hara H., Nakatsu Y., Aizawa T. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention

By Mehta R.H., Harjai K.J., Cox D., Stone G.W., Brodie B., Boura J., O'Neill W., Grines C.L., Primary Angioplasty in Myocardial Infarction PAMI Investigators in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

By Title L.M., Giddens K., McInerney M.M., McQueen M.J., Nassar B.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Coxibs and the endothelium

By Verma S., Szmitko P.E. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S., Cowan D., Kaski J.-C. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors as therapeutic targets in inflammation

By Plutzky J. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite